サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1507987

生殖補助医療の世界市場、2033年までの機会と戦略

Assisted Reproductive Technology Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 393 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
生殖補助医療の世界市場、2033年までの機会と戦略
出版日: 2024年07月04日
発行: The Business Research Company
ページ情報: 英文 393 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の生殖補助医療（ART）市場は2018年に286億2,400万米ドルと評価され、2023年までCAGR5.0％以上で成長しました。

PCOSの有病率の増加

PCOS（多嚢胞性卵巣症候群）の有病率の高さは、実績期間における生殖補助医療市場の成長を支えました。PCOSは生殖年齢の女性に起こるホルモン障害です。卵巣を持つ生殖年齢層で最も一般的な内分泌（ホルモン）疾患で、控えめに見てもその人口の5～10％が罹患しています。ARTはPCOSの患者さんに合わせた治療の選択肢を提供し、PCOSに関連する生殖に関する特定の課題に対処し、妊娠や妊娠を成功させる可能性を高めます。体外受精は、卵巣から卵子を採取し、実験室で精子と受精させ、得られた胚を子宮に移植する、より高度なART治療法です。PCOSは女性不妊症の主要な原因の一つであり、「無排卵性」（排卵がない）不妊症の80％を占めると推定されています。体外受精は、PCOSの女性の受胎能力を高めるための最も一般的な治療のひとつです。さらに、スイスの専門機関であるWHOによると、全世界で約1億1,600万人（3.4％）の女性がPCOSに罹患しているといいます。したがって、PCOSの症例の増加が、歴史的な期間における生殖補助医療市場の成長を牽引しました。

目次

第1章 エグゼクティブサマリー

  • 生殖補助医療-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 生殖補助医療市場定義とセグメンテーション
  • 市場セグメンテーション：技術別
    • 体外受精（IVF）
    • 人工授精（AI-IUI）
    • その他のテクノロジー
  • 市場セグメンテーション：手順の種類別
    • 新鮮な非ドナー
    • 新規ドナー
    • 凍結ドナー
    • 凍結された非ドナー
    • 胚または卵子のバンキング
  • 市場セグメンテーション：エンドユーザー別
    • 病院
    • 不妊治療クリニック
    • その他のエンドユーザー
  • 市場セグメンテーション診断：検査別
    • 排卵検査
    • 子宮卵管造影検査
    • 卵巣予備能検査
    • 遺伝子検査
    • その他のテスト

第7章 主要な市場動向

  • ARTの推進と持続可能性の支援を目的とした革新的なプログラムを立ち上げる主要企業
  • 生殖補助医療における人工知能の影響
  • 生殖補助医療における先進技術ソリューション
  • 生殖補助医療におけるブロックチェーンの統合
  • 生殖補助医療技術の革新を推進する戦略的コラボレーション
  • 革新的な不妊治療オプションで医療へのアクセスを向上

第8章 生殖補助医療市場：マクロ経済シナリオ

  • COVID-19の影響：生殖補助医療市場
  • ウクライナ戦争の影響：生殖補助医療市場
  • 高インフレの影響：生殖補助医療市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績, 2018-2023
    • 市場促進要因2018-2023
    • 市場抑制要因2018-2023
  • 市場成長予測, 2023-2028, 2033年
    • 市場促進要因2023-2028
    • 市場抑制要因2023-2028

第10章 世界の生殖補助医療市場：セグメンテーション

  • 世界の生殖補助医療市場：技術別、実績と予測, 2018-2023, 2028年, 2033年
  • 世界の生殖補助医療市場：手順タイプ別、実績と予測, 2018-2023, 2028年, 2033年
  • 世界の生殖補助医療市場：エンドユーザー別、実績と予測, 2018-2023, 2028年, 2033年
  • 生殖補助医療検査市場（ART検査/診断）、実績と予測, 2018-2023, 2028年, 2033年
    • 世界のその他の検査市場：ART検査/診断別、実績と予測, 2018-2023, 2028年, 2033年

第11章 生殖補助医療市場：地域・国別分析

  • 世界の生殖補助医療市場：地域別、実績と予測, 2018-2023, 2028年, 2033年
  • 世界の生殖補助医療市場：国別、実績と予測, 2018-2023, 2028年, 2033年

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • Vitrolife AB
  • Ferring B.V.
  • Progyny Inc.
  • CooperSurgical Inc.
  • FUJIFILM Irvine Scientific, Inc.

第20章 競合ベンチマーキング

第21章 競合ダッシュボード

第22章 主要な合併と買収

  • Hamilton Thorne Acquired Gynetics Medical Products
  • Reproductive Medicine Associates（RMA）And IVI-RMA Acquired Conceptions Reproductive Associates of Colorado
  • BPEA EQT Acquired Indira IVF
  • Calibre Scientific Acquired Microm UK Limited And Scopescreen
  • Liverpool Partners Acquired Genea Ltd.

第23章 機会と戦略

  • 世界の生殖補助医療市場2028：新たな機会を提供する国
  • 世界の生殖補助医療市場2028：新たな機会を提供するセグメント
  • 世界の生殖補助医療市場2028：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第24章 生殖補助医療市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第25章 付録

目次
Product Code: o&s1246

Assisted reproductive technology (ART) refers to fertility treatments and procedures that involve the manipulation of eggs, sperm or embryos to increase the likelihood of a successful pregnancy in humans. ART includes all fertility treatments in which either the eggs or the embryos are handled.

The assisted reproductive technology (ART) market consists of sales, by entities (organizations, sole traders and partnerships), of assisted reproductive technology (ART) procedures that are used for the treatment of infertility.

The global assisted reproductive technology (ART) market was valued at $28,624.0 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 5.0%.

Increasing Prevalence Of PCOS

The high prevalence of PCOS (polycystic ovary syndrome) condition supported the assisted reproductive technology market growth in the historic period. PCOS is a hormonal disorder that occurs in women of reproductive age. It is the most common endocrine (hormone) disorder in reproductive-age people with ovaries, affecting, conservatively, 5-10% of that population. ART offers tailored treatment options for individuals with PCOS, addressing the specific reproductive challenges associated with the condition and increasing the likelihood of successful conception and pregnancy. IVF is a more advanced ART procedure that involves the retrieval of eggs from the ovaries, fertilization with sperm in a laboratory setting, and transferring resulting embryos into the uterus. PCOS is one of the leading causes of female infertility, responsible for an estimated 80% of "anovulatory" (no ovulation) infertility cases. IVF is one of the most common treatments for women to increase fertility in women with PCOS. Furthermore, according to WHO, a Switzerland-based specialized agency, approximately 116 million women (3.4%) are affected by PCOS globally. Therefore, increased cases of PCOS drove the assisted reproductive technology market growth in the historic period.

Impact Of Artificial Intelligence On Assisted Reproductive Technology

Several key players operating in the assisted reproductive technology market are integrating efforts to introduce technological innovations, such as artificial intelligence (AI) software, to advance IVF treatment outcomes and lower the costs of the treatment. In IVF, AI algorithms analyze vast amounts of data from patient medical records, lab tests and imaging studies to identify patterns and make predictions. For instance, in October 2022, Alife, a US-based AI-based health technology firm, launched new artificial intelligence software to help fertility clinics optimize and support clinical decision-making during critical stages of the IVF process. Alife uses AI and significant U.S. IVF data sets to examine millions of patient cycle data points. The company's technology can help optimize the IVF treatment process from start to finish by reducing clinic operations and giving patients a more tailored experience.

The global assisted reproductive technology market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 17.9% of the total market in 2022.

Assisted Reproductive Technology Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global assisted reproductive technology market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for assisted reproductive technology? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The assisted reproductive technology market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider assisted reproductive technology market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by diagnosis/testing, by procedure type and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the assisted reproductive technology market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by technology, by diagnosis/testing, by procedure type and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for assisted reproductive technology providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Technology: In Vitro-Fertilization (IVF); Artificial Insemination (AI-IUI); Other Technologies
  • 2) By Procedure Type: Fresh Non-Donor; Fresh Donor; Frozen Donor; Frozen Non-Donor; Embryo or Egg Banking
  • 3) By End-User: Hospitals; Fertility Clinics; Other End-Users
  • 4) By Testing/Diagnosis: In Ovulation Testing; Hysterosalpingography; Ovarian Reserve Testing; Genetic Testing; Other Tests
  • Companies Mentioned: Vitrolife; Ferring B.V.; Progyny Inc.; CooperSurgical Inc.; FUJIFILM Irvine Scientific, Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; assisted reproductive technology indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Assisted Reproductive Technology - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Assisted Reproductive Technology Market Definition And Segmentations
  • 6.4 Market Segmentation By Technology
    • 6.4.1 In Vitro-Fertilization (IVF)
    • 6.4.2 Artificial Insemination (AI-IUI)
    • 6.4.3 Other Technologies
  • 6.5 Market Segmentation By Procedure Type
    • 6.5.1 Fresh Non-Donor
    • 6.5.2 Fresh Donor
    • 6.5.3 Frozen Donor
    • 6.5.4 Frozen Non-Donor
    • 6.5.5 Embryo Or Egg Banking
  • 6.6 Market Segmentation By End-User
    • 6.6.1 Hospitals
    • 6.6.2 Fertility Clinics
    • 6.6.3 Other End-Users
  • 6.7 Market Segmentation By Diagnosis/Testing
    • 6.7.1 Ovulation Testing
    • 6.7.2 Hysterosalpingography
    • 6.7.3 Ovarian Reserve Testing
    • 6.7.4 Genetic Testing
    • 6.7.5 Other Test
      • 6.7.5.1 Computer Assisted Semen Analysis
      • 6.7.5.2 Sperm Penetration Assay
      • 6.7.5.3 Microscopic Examination
      • 6.7.5.4 Others Testing/Diagnosis

7 Major Market Trends

  • 7.1 Key Players Launching Innovative Programs To Promote ART and Support Sustainability
  • 7.2 Impact Of Artificial Intelligence On Assisted Reproductive Technology
  • 7.3 Advanced Technological Solutions In Assisted Reproductive Technology
  • 7.4 Blockchain Integration In Assisted Reproductive Technology
  • 7.5 Strategic Collaborations Driving Innovation In Assisted Reproductive Technology
  • 7.6 Innovative Fertility Treatment Options To Enhance Access To Care

8 Assisted Reproductive Technology Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Assisted Reproductive Technology Market
  • 8.2 Impact Of The War In Ukraine On The Assisted Reproductive Technology Market
  • 8.3 Impact Of High Inflation On The Assisted Reproductive Technology Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Assisted Reproductive Technology Market Segmentation

  • 10.1 Global Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
    • 10.4.1 Global Other Tests Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Assisted Reproductive Technology Market, Regional and Country Analysis

  • 11.1 Global Assisted Reproductive Technology Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Assisted Reproductive Technology Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Assisted Reproductive Technology Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
    • 12.8.1 Market Overview
    • 12.8.2 Country Information
    • 12.8.3 Market Information
    • 12.8.4 Background Information
    • 12.8.5 Government Initiatives
    • 12.8.6 Regulations
    • 12.8.7 Regulatory Bodies
    • 12.8.8 Major Associations
    • 12.8.9 Taxes Levied
    • 12.8.10 Corporate Tax Structure
    • 12.8.11 Investments
    • 12.8.12 Major Companies
  • 12.9 China Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 India Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Market
  • 12.19 Japan Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Japan Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Japan Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Market
  • 12.24 Australia Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Australia Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Australia Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Australia Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Market
  • 12.29 Indonesia Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 Indonesia Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 Indonesia Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 Indonesia Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.33 South Korea Market
  • 12.34 South Korea Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.35 South Korea Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.36 South Korea Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.37 South Korea Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 Western Europe Assisted Reproductive Technology Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 UK Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 UK Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Market
  • 13.13 Germany Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 Germany Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 Germany Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 Germany Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Market
  • 13.18 France Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 France Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 France Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 France Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Italy Market
  • 13.23 Italy Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Italy Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Italy Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.26 Italy Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.27 Spain Market
  • 13.28 Spain Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.29 Spain Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.30 Spain Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.31 Spain Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Assisted Reproductive Technology Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.10 Russia Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.11 Russia Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 North America Assisted Reproductive Technology Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
    • 15.8.1 Market Overview
    • 15.8.2 Country Information
    • 15.8.3 Market Information
    • 15.8.4 Background Information
    • 15.8.5 Government Initiatives
    • 15.8.6 Regulations
    • 15.8.7 Regulatory Bodies
    • 15.8.8 Major Associations
    • 15.8.9 Taxes Levied
    • 15.8.10 Corporate Tax Structure
    • 15.8.11 Investments
    • 15.8.12 Major Companies
  • 15.9 USA Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 USA Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 USA Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Market
  • 15.14 Canada Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Canada Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.17 Canada Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 South America Assisted Reproductive Technology Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.10 Brazil Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.11 Brazil Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Assisted Reproductive Technology (ART) Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Assisted Reproductive Technology (ART) Market, Segmentation By Procedure Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Assisted Reproductive Technology Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Assisted Reproductive Technology (ART) Testing Market, Segmentation By ART Testing/Diagnosis, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Vitrolife AB
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
    • 19.1.3 Business Strategy
    • 19.1.4 Financial performance
  • 19.2 Ferring B.V.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial performance
  • 19.3 Progyny Inc.
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Performance
  • 19.4 CooperSurgical Inc.
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 FUJIFILM Irvine Scientific, Inc.
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Hamilton Thorne Acquired Gynetics Medical Products
  • 22.2 Reproductive Medicine Associates (RMA) And IVI-RMA Acquired Conceptions Reproductive Associates of Colorado
  • 22.3 BPEA EQT Acquired Indira IVF
  • 22.4 Calibre Scientific Acquired Microm UK Limited And Scopescreen
  • 22.5 Liverpool Partners Acquired Genea Ltd.

23 Opportunities And Strategies

  • 23.1 Global Assisted Reproductive Technology Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Assisted Reproductive Technology Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Assisted Reproductive Technology Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Assisted Reproductive Technology Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer